A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.

A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.

BACKGROUND:Data on the true prevalence of hepatitis C virus (HCV) infection in the general population is essential. We evaluated a program implementing free universal HCV screening using a non-invasive point-of-care test (POCT) (OraQuick-HCV rapid test) in oral fluid in an urban area in Valencia, So...

Full description

Bibliographic Details
Main Authors:	Ângela Carvalho-Gomes, Almudena Cubells, Carmina Pallarés, Vanessa Hontangas, Isabel Conde, Tomasso Di Maira, Salvador Peiró, Gabriel Sanfélix-Gimeno, F Xavier López-Labrador, Marina Berenguer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0228351

Similar Items

Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.
by: Julián Librero, et al.
Published: (2016-01-01)

Variabilidad en la utilización de antihipertensivos entre las zonas básicas de salud de la Comunidad Valenciana Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2010-10-01)

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study
by: Isabel Hurtado, et al.
Published: (2020-12-01)

Caracterización de la suplementación de folatos en el embarazo a partir de la combinación de sistemas de información sanitaria Characterization of folate supplementation in pregnancy, based on a combination of health information systems
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2012-12-01)

Dispensación personalizada de medicamentos en las oficinas de farmacia: ¿una medida basada en la evidencia? Personalized drug dispensation in retail pharmacies: an evidence-based measure?
by: Salvador Peiró, et al.
Published: (2011-04-01)

Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study)
by: Reig-Molla Begoña, et al.
Published: (2011-04-01)

When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.
by: Ferrán Catalá-López, et al.
Published: (2013-01-01)

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
by: Isabel Hurtado-Navarro, et al.
Published: (2019-07-01)

Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?
by: González López-Valcárcel Beatriz, et al.
Published: (2011-12-01)

Real-World Patterns of Pharmacotherapeutic Management of Asthma Patients With Exacerbations in the Spanish National Health System
by: Isabel Hurtado, et al.
Published: (2020-08-01)

Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2015-01-01)

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
by: Aníbal García-Sempere, et al.
Published: (2017-08-01)

Sulfato de glucosamina: eficacia todavía en debate
by: José Sanfélix Genovés, et al.
Published: (2014-09-01)

Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain.
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2018-01-01)

Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2018-04-01)

Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies
by: Catalá-López Ferrán, et al.
Published: (2012-10-01)

Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study
by: Pascual de la Torre Manuel, et al.
Published: (2010-10-01)

Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study
by: Fluixá Carlos, et al.
Published: (2010-03-01)

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain
by: Isabel Hurtado-Navarro, et al.
Published: (2018-12-01)

Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD Study
by: Ruiz Vicente, et al.
Published: (2011-08-01)

Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System
by: Librero Julián, et al.
Published: (2012-01-01)

New developments in the management of hepatitis C virus infection: focus on boceprevir
by: Berenguer M, et al.
Published: (2012-08-01)

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study.
by: Aníbal García-Sempere, et al.
Published: (2019-01-01)

Hepatitis C and liver transplantation
by: Rosalba Moreno, et al.
Published: (2002-07-01)

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis.
by: Ferrán Catalá-López, et al.
Published: (2012-01-01)

A case of autoimmune hepatitis with positive hepatitis C antibody
by: LYU Jing, et al.
Published: (2016-05-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
by: Muriel Lavie, et al.
Published: (2018-04-01)

Predictive Performance of the FRAX Tool Calibrated for Spain vs. an Age and Sex Model: Prospective Cohort Study with 9082 Women and Men Followed for up to 8 Years
by: García-Sempere, A., et al.
Published: (2022)

Hepatitis C tras el trasplante hepático: Historia natural y factores de riesgo de evolución desfavorable.
by: Berenguer Haym, Marina
Published: (2001)

Hepatitis B antigen and antibodies
by: Moodie, John Wykeham
Published: (2017)

ANÁLISIS POBLACIONAL POR ÁREAS DE SALUD DE LAS VARIACIONES EN CONSUMO, PRECIO Y GASTO DE MEDICAMENTOS CARDIOVASCULARES EN 8 COMUNIDADES AUTÓNOMAS, ESPAÑA, 2005
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2010-01-01)

Detection of antibodies to hepatitis A virus in saliva and urine
by: Perry, Keith Railton
Published: (1996)

Hepatitis C and fibrosis
by: V. Aguilera, et al.

Recombination in Hepatitis C Virus
by: María Alma Bracho, et al.
Published: (2011-10-01)

Hepatitis C and fibrosis Virus de la hepatitis C y fibrosis
by: V. Aguilera, et al.
Published: (2004-06-01)

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
by: Carmen Vinaixa, et al.
Published: (2017-05-01)

Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
by: Verónica Gamón, et al.
Published: (2021-06-01)

Hepatitis A antibodies in two socioeconomically distinct populations of São Paulo, Brazil
by: Claudio Sergio Pannuti, et al.
Published: (1985-06-01)

Crónica de una tertulia esperada Chronicle of a foretold chat
by: Salvador Peiró
Published: (2007-12-01)

Hepatitis C Vaccines, Antibodies, and T Cells
by: Naglaa H. Shoukry, et al.
Published: (2018-06-01)